Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
oleh: Andre De Souza, Fabio A. Tavora, Devalingam Mahalingam, Pamela N. Munster, Howard P. Safran, Wafik S. El-Deiry, Wafik S. El-Deiry, Benedito A. Carneiro
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2020-10-01 |
Deskripsi
Subjek
glycogen synthase kinase-3 (GSK3); glycogen synthase kinase-3 (GSK-3) inhibitor; COVID; COVID-19; 9-ING-41; GSK-3b inhibitor